Literature DB >> 15802640

Identification of mouse brain proteins associated with isoform 3 of metallothionein.

David W Lahti1, John D Hoekman, Abigail M Tokheim, Bruce L Martin, Ian M Armitage.   

Abstract

Using immunological approaches and mass spectrometry, five proteins associated with metallothionein-3 in mouse brains have been identified. Metallothionein-3 and associated proteins were isolated using immunoaffinity chromatography over immobilized anti-mouse brain MT3 antibody. Proteins in the recovered pool were separated by SDS-polyacrylamide gel electrophoresis, and distinct bands were excised and the proteins digested using trypsin. Peptides were extracted and analyzed using electrospray ionization mass spectrometry. Initial identification was done comparing the identified peptide mass:charge ratios to the MASCOT database. Confirmation of proteins was accomplished by sequencing of selected peptides using tandem mass spectrometry and comparison to the MASCOT database. The proteins were heat-shock protein 84 (mouse variant of heat-shock protein 90), heat-shock protein 70, dihydropyrimidinase-like protein 2, creatine kinase, and beta actin. Independently using antibodies against metallothionein-3, creatine kinase, and heat-shock protein 84 showed that all three proteins were coimmunoprecipitated from whole mouse brain homogenates with each of the three antibodies. Mixing purified samples of metallothionein and human brain creatine kinase also generated a complex that could be immunoprecipitated either by anti-metallothionein-3 or anticreatine kinase antibody. These data are consistent with metallothionein-3 being present in the mouse brain as part of a multiprotein complex providing new functional information for understanding the role of metallothionein-3 in neuronal physiology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15802640      PMCID: PMC2253260          DOI: 10.1110/ps.041113005

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  35 in total

1.  The expression of creatine kinase isoenzymes in neocortex of patients with neurodegenerative disorders: Alzheimer's and Pick's disease.

Authors:  M Y Aksenov; M V Aksenova; R M Payne; C D Smith; W R Markesbery; J M Carney
Journal:  Exp Neurol       Date:  1997-08       Impact factor: 5.330

2.  Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels.

Authors:  A Shevchenko; M Wilm; O Vorm; M Mann
Journal:  Anal Chem       Date:  1996-03-01       Impact factor: 6.986

3.  Metallothionein-III prevents glutamate and nitric oxide neurotoxicity in primary cultures of cerebellar neurons.

Authors:  C Montoliu; P Monfort; J Carrasco; O Palacios; M Capdevila; J Hidalgo; V Felipo
Journal:  J Neurochem       Date:  2000-07       Impact factor: 5.372

4.  Cu2+ and Zn2+ inhibit nitric-oxide synthase through an interaction with the reductase domain.

Authors:  J M Perry; Y Zhao; M A Marletta
Journal:  J Biol Chem       Date:  2000-05-12       Impact factor: 5.157

5.  Disruption of the metallothionein-III gene in mice: analysis of brain zinc, behavior, and neuron vulnerability to metals, aging, and seizures.

Authors:  J C Erickson; G Hollopeter; S A Thomas; G J Froelick; R D Palmiter
Journal:  J Neurosci       Date:  1997-02-15       Impact factor: 6.167

6.  Metallothionein isoform 3 expression in the human prostate and cancer-derived cell lines.

Authors:  S H Garrett; M A Sens; D Shukla; S Nestor; S Somji; J H Todd; D A Sens
Journal:  Prostate       Date:  1999-11-01       Impact factor: 4.104

7.  Inhibition of nitric oxide synthase activity by Zn2+ ion.

Authors:  A Persechini; K McMillan; B S Masters
Journal:  Biochemistry       Date:  1995-11-21       Impact factor: 3.162

8.  Expression of human metallothionein-III in transgenic mice.

Authors:  J C Erickson; B A Masters; E J Kelly; R L Brinster; R D Palmiter
Journal:  Neurochem Int       Date:  1995-07       Impact factor: 3.921

9.  Constitutive expression of metallothionein-III (MT-III), but not MT-I, inhibits growth when cells become zinc deficient.

Authors:  R D Palmiter
Journal:  Toxicol Appl Pharmacol       Date:  1995-11       Impact factor: 4.219

10.  Metallothionein isoform 3 as a potential biomarker for human bladder cancer.

Authors:  M A Sens; S Somji; D L Lamm; S H Garrett; F Slovinsky; J H Todd; D A Sens
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

View more
  8 in total

1.  Characterization of the role of metallothionein-3 in an animal model of Alzheimer's disease.

Authors:  Yasmina Manso; Javier Carrasco; Gemma Comes; Gabriele Meloni; Paul A Adlard; Ashley I Bush; Milan Vašák; Juan Hidalgo
Journal:  Cell Mol Life Sci       Date:  2012-06-22       Impact factor: 9.261

2.  Role of zinc metallothionein-3 (ZnMt3) in epidermal growth factor (EGF)-induced c-Abl protein activation and actin polymerization in cultured astrocytes.

Authors:  Sook-Jeong Lee; Kyung-Sook Cho; Ha Na Kim; Hyun-Jae Kim; Jae-Young Koh
Journal:  J Biol Chem       Date:  2011-09-07       Impact factor: 5.157

3.  Changes in Copper, Zinc, Arsenic, Mercury, and Lead Concentrations in Rat Biofluids and Tissues Induced by the "Renqing Changjue" Pill, a Traditional Tibetan Medicine.

Authors:  Lan Zhang; Caidan Rezeng; Yingfeng Wang; Zhongfeng Li
Journal:  Biol Trace Elem Res       Date:  2021-01-19       Impact factor: 3.738

4.  Protein interactions with metallothionein-3 promote vectorial active transport in human proximal tubular cells.

Authors:  Gazal Kalyan; Andrea Slusser-Nore; Jane R Dunlevy; Chandra S Bathula; John B Shabb; Wallace Muhonen; Seema Somji; Donald A Sens; Scott H Garrett
Journal:  PLoS One       Date:  2022-05-03       Impact factor: 3.752

5.  Gains, losses and changes of function after gene duplication: study of the metallothionein family.

Authors:  Ana Moleirinho; João Carneiro; Rune Matthiesen; Raquel M Silva; António Amorim; Luísa Azevedo
Journal:  PLoS One       Date:  2011-04-25       Impact factor: 3.240

6.  New proteins found interacting with brain metallothionein-3 are linked to secretion.

Authors:  Issam El Ghazi; Bruce L Martin; Ian M Armitage
Journal:  Int J Alzheimers Dis       Date:  2010-12-27

Review 7.  The Function of Transthyretin Complexes with Metallothionein in Alzheimer's Disease.

Authors:  Natalia Zaręba; Marta Kepinska
Journal:  Int J Mol Sci       Date:  2020-11-26       Impact factor: 5.923

Review 8.  Metallothionein-3 as a multifunctional player in the control of cellular processes and diseases.

Authors:  Jae-Young Koh; Sook-Jeong Lee
Journal:  Mol Brain       Date:  2020-08-25       Impact factor: 4.041

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.